Articles Tagged With: Contraception
-
Shift to Telehealth Could Remain Trend After COVID-19
Telehealth was a small part of family planning before the COVID-19 pandemic. The landscape likely will look markedly different for telemedicine strategies after the pandemic.
-
Rheumatology Association Issues Its First Reproductive Health Guidelines
The 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases is the first set of evidence-based recommendations regarding contraception and other reproductive health issues from the American College of Rheumatology.
-
Title X Final Rule Is Troubling for Providers
The recent Title X changes enacted by the Trump administration are creating major ethical dilemmas and operational challenges for family planning and reproductive health clinics nationwide.
-
Title X Problems Worsen with Recent Court Decision
The recent Title X changes have proven devastating to women depending on family planning centers for their reproductive healthcare needs. The 9th U.S. Circuit Court of Appeals ruling upheld the Trump administration’s gag rule that prohibits Title X providers from referring patients for abortion care or even answering questions about abortion.
-
COVID-19 Shuts Down Nation; Family Planning Need Not Stop
The COVID-19 pandemic has affected every aspect of American life, including nonemergency doctor visits. But from a family reproductive health point of view, the consequences of weeks of social distancing and quarantines can present new challenges.
-
Can We Liberalize Intrauterine Device Insertion Protocols?
In this retrospective cohort study, the rate of luteal phase pregnancy was 0.4% among 239 women who did not meet pregnancy checklist criteria for intrauterine device insertion.
-
Long-Lasting, Woman-Controlled Contraception Is Here
Annovera is designed for 21 days of continuous use, followed by a seven-day ring-free interval, during which the ring is removed, washed, and stored. Unlike other products, the same ring is used for subsequent cycles for an entire year (13 cycles total).
-
The Affordable Care Act: Progress in Reducing the Rate of Unintended Pregnancy
Data from the latest release of the National Survey of Family Growth supports that the contraception coverage mandate of the Affordable Care Act has resulted in a decrease in the incidence of unintended pregnancy, particularly among women with government coverage.
-
Revamping the Daily Pill: Research to Begin on Monthly Pill
Although lowering side effects plays an important role in oral contraceptive compliance, one of the biggest challenges for patients is adhering to the daily schedule of the pill. Forgetting one to three pills per cycle is a frequent problem among 15-51% of users, particularly among adolescents. Lyndra Therapeutics has received a $13 million grant from the Bill & Melinda Gates Foundation and is setting out to remove the daily pill compliance challenge. The company is in early development of a monthly oral contraceptive to provide women with a discreet, noninvasive, reversible contraception option.
-
Hormonal Contraception and HIV: Does DMPA Increase Risk of Transmission?
This special feature includes a review of the evidence for the effect of hormonal and nonhormonal methods on HIV risk.